
CAS Number316-46-1
SynonymsL-5-Fluorouridine; FURD; 5-fluoro-uridine; FUR; 5-FLUOROIDINE; 5-fur; 5-Fluor-uridin; EINECS 206-260-3; MFCD00036832; 5-Fluorouridine; 5-FUrd; 5-fluoro-uridin; 1-(β-D-Ribofuranosyl)-5-fluorouracil; FLUOROURIDINE; 5-FU
Molecular FormulaC9H11FN2O6
Molecular Weight262.19
Purity≥99 (HPLC)%
Density1.8±0.1 g/cm3
Melting Point182-184 °C
Appearancepowder
EINECS206-260-3
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 316-46-1 |
| Catalog No. | 2A-9021232 |
| Chinese Name | 5-氟尿嘧啶核苷 |
| Synonyms | L-5-Fluorouridine; FURD; 5-fluoro-uridine; FUR; 5-FLUOROIDINE; 5-fur; 5-Fluor-uridin; EINECS 206-260-3; MFCD00036832; 5-Fluorouridine; 5-FUrd; 5-fluoro-uridin; 1-(β-D-Ribofuranosyl)-5-fluorouracil; FLUOROURIDINE; 5-FU |
| Molecular Formula | C9H11FN2O6 |
| Molecular Weight | 262.19 |
| Purity | ≥99 (HPLC) |
| Density | 1.8±0.1 g/cm3 |
| Melting Point | 182-184 °C |
| Appearance | powder |
| Water Solubility | soluble |
| Storage Condition | Room temperature, sealed, dry |
| Application | 5-Fluorouridine is a metabolite of 5-fluorouracil and has anticancer activity. 5-Fluorouridine inhibits rRNA synthesis in human colon cancer cells. 5-Fluorouridine has a cytotoxic effect on the growth |
| EINECS | 206-260-3 |
| HTC | 2942000000 |
| PubChem ID | 24894883 |
| MDL Number | MFCD00036832 |
| SMILES | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=C(F)C(=O)NC2=O |
| InChI | 1S/C9H11FN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6-,8-/m1/s1 |
| InChI Key | FHIDNBAQOFJWCA-UAKXSSHOSA-N |
| Beilstein/REAXYS | 33662 |
| NACRES Code | NA.51 |
| UNSPSC | 41106305 |
| Hazard Symbols | Transport |
| MSDS | msds/21232_1_316_46_1.pdf |
| Bioactivity | 5-Fluorouridine is a metabolite of 5-fluorouracil with anticancer activity[1][2][3][4]. 5-fluorouridine inhibits rRNA synthesis of human colon carcinoma cells[3]. 5-Fluorouridine exhibits cytotoxic effect on growth of L1210 cells with an IC50 of 2 nM[4]. Related Catalog Research Areas >> Cancer Signaling Pathways >> Others >> Others References [1]. Wu FL , et al. Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2'-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics. Cancer Lett. 2015 Jul 10;363(1):7-16. [2]. Hu N, et al. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine. Cell Physiol Biochem. 2017;44(6):2158-2173. [3]. Glazer RI, et al. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. Mol Pharmacol. 1982 Mar;21(2):468-73. [4]. Kanzawa F, et al. Differences between 5-fluoro-2'-deoxyuridine and 5-fluorouridine in their cytotoxic effect on growth of murine lymphoma L5178Y cells in in vivo and in vitro systems. Eur J Cancer. 1980 Aug;16(8):1087-92. Chemical & Physical Properties Density 1.8±0.1 g/cm3 Melting Point 182-184 °C Molecular Formula C9H11FN2O6 Molecular Weight 262.192 Exact Mass 262.060120 PSA 124.78000 LogP -1.34 Index of Refraction 1.641 InChIKey FHIDNBAQOFJWCA-UAKXSSHOSA-N SMILES O=c1[nH]c(=O)n(C2OC(CO)C(O)C2O)cc1F Water Solubility soluble |
| Use of | Properties Articles38 Name 5-fluorouridine Synonym More Synonyms 5-Fluorouridine Biological Activity Related Catalog Research Areas >> Cancer Signaling Pathways >> Others >> Others References [1]. Wu FL , et al. Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2'-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics. Cancer Lett. 2015 Jul 10;363(1):7-16. [2]. Hu N, et al. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine. Cell Physiol Biochem. 2017;44(6):2158-2173. [3]. Glazer RI, et al. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. Mol Pharmacol. 1982 Mar;21(2):468-73. [4]. Kanzawa F, et al. Differences between 5-fluoro-2'-deoxyuridine and 5-fluorouridine in their cytotoxic effect on growth of murine lymphoma L5178Y cells in in vivo and in vitro systems. Eur J Cancer. 1980 Aug;16(8):1087-92. Chemical & Physical Properties Molecular Formula C9H11FN2O6 Exact Mass 262.060120 PSA 124.78000 LogP -1.34 Index of Refraction 1.641 InChIKey FHIDNBAQOFJWCA-UAKXSSHOSA-N SMILES O=c1[nH]c(=O)n(C2OC(CO)C(O)C2O)cc1F Water Solubility soluble |
| Transport Info | Product name: Purity: 98.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available See reverse side of invoice or packing slip. |
| Related Products in Biotechnology & Diagnostics | ||
|---|---|---|
| Floxuridine | 50-91-9 | 2A-9016586 |
| Triphosphopyridine nucleotide | 53-59-8 | 2A-9016651 |
| (+)-5-Iodo-2'-deoxyuridine | 54-42-2 | 2A-9016664 |
| Inosine | 58-63-9 | 2A-9016786 |
| Broxuridine | 59-14-3 | 2A-9016804 |
| 2',3'-O-Isopropylideneadenosine | 362-75-4 | 2A-9021503 |
| 2',3'-O-Isopropylideneguanosine | 362-76-5 | 2A-9021504 |
| beta-Nicotinamide adenine dinucleotide disodium salt | 606-68-8 | 2A-9024041 |
| 5-Iodo-2'-deoxycytidine | 611-53-0 | 2A-9024139 |
| 2'-Deoxyadenosine 5'-phosphate | 653-63-4 | 2A-9024746 |
| Browse all Biotechnology & Diagnostics products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA